Crossmark

Intrathecal delivery of AAVrh10-mHexa combined with anti-inflammatory treatment reduces neuropathological markers and extends the lifespan of mice with early-onset Tay-Sachs disease

Crossref DOI link: https://doi.org/10.1007/s11011-026-01802-2

Published Online: 2026-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Can, Melike https://orcid.org/0000-0001-7935-7077
Ausseil, Jerome https://orcid.org/0000-0002-3059-9777
Seyrantepe, Volkan https://orcid.org/0000-0002-0243-5011
Funding

Funding for this research was provided by:

Izmir Institute of Technology
License Information

Text and Data Mining valid from 2026-02-25

Version of Record valid from 2026-02-25
More Information

Article History

Received: 26 September 2025

Accepted: 30 January 2026

First Online: 25 February 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below